Eli Lilly and Gilead’s combination cuts COVID-19 recovery time

Eli Lilly and Gilead’s combination cuts COVID-19 recovery time

Source: 
Pharmaforum
snippet: 

Eli Lilly’s Olumiant (baricitinib) has a significant effect on recovery from COVID-19 when combined with Gilead Veklury (remdesivir), according to a large trial backed by funding from the US government.